Strategies and Applications of Antigen-Binding Fragment (Fab) Production in Escherichia coli
With the advancement of genetic engineering, monoclonal antibodies (mAbs) have made far-reaching progress in the treatment of various human diseases. However, due to the high cost of production, the increasing demands for antibody-based therapies have not been fully met. Currently, mAb-derived alter...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Georg Thieme Verlag KG
2021-06-01
|
| Col·lecció: | Pharmaceutical Fronts |
| Matèries: | |
| Accés en línia: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1735145 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|